Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Your view on ISRG
Overview
What the company does, where it operates, and who runs it.
About Intuitive Surgical, Inc.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- David J. Rosa
- Headquarters
- 1020 Kifer Road, Sunnyvale, CA, US
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- David J. Rosa
- Headquarters
- 1020 Kifer Road, Sunnyvale, CA, US
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights.
The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Intuitive Surgical, Inc., and the rating behind it. ISRG last traded at $369.15, 42.0× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Intuitive Surgical, Inc.. Starting points for Intuitive Surgical, Inc.: P/E 42.0, EPS $8.85, beta 1.47 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Intuitive Surgical, Inc.. Intuitive Surgical, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Intuitive Surgical, Inc.. Trailing twelve-month EPS for Intuitive Surgical, Inc. stands at $8.85. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Intuitive Surgical, Inc.. Intuitive Surgical, Inc. has reported as a listed company since 2000. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Intuitive Surgical, Inc. valued side by side against its closest peers. Intuitive Surgical, Inc. is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Intuitive Surgical, Inc., and how their positions are changing. At a $130.41B market value, institutional positions materially move Intuitive Surgical, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Intuitive Surgical, Inc. executives and directors. Shares of Intuitive Surgical, Inc. have traded between $425.00 and $616.00 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Intuitive Surgical, Inc.. Intuitive Surgical, Inc. is a $130.41B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Intuitive Surgical, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Intuitive Surgical, Inc.. Coverage tracks Intuitive Surgical, Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.